INTS Competitors & Alternatives
Compare Intensity Therapeutics, Inc. Common stock with similar stocks in the same industry
Biotechnology
INTS
Main Stock$4.80
Tradestie Score
40
Market Cap
$12.65M
Analyst Upside
+302.9%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PRLD
Prelude Therapeutics Incorporated
|
$6.61
|
$85.47M | - | 43 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.33
|
$84.52M | - | 45 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$4.50
|
$71.69M | - | 48 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$11.18
|
$71.32M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.37
|
$67.94M | - | 41 | Compare |
|
AIRE
reAlpha Tech Corp. Common Stock
|
$1.66
|
$64.14M | - | 50 | Compare |
|
IXHL
Incannex Healthcare Limited American Depositary Shares
|
$3.61
|
$40.49M | - | 39 | Compare |
|
MSAI
MultiSensor AI Holdings, Inc. Common Stock
|
$5.42
|
$22.52M | - | 35 | Compare |
|
FEMY
Femasys Inc. Common Stock
|
$3.08
|
$16.15M | - | 53 | Compare |
|
PCSA
Processa Pharmaceuticals, Inc. Common
|
$2.14
|
$11.06M | 3.3 | 46 | Compare |
More INTS Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2836)
242 stocks in this industry